Portfolio (Quarterly)
Guide ↗
Persistent Asset Partners Ltd
· CIK 0002056052| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 101 | SPLV | INVESCO EXCH TRADED FD TR II | — | 7,680.0 | $575K | 0.17% | NEW | — | $74.90 | -1.4% |
| 102 | AVBP | ARRIVENT BIOPHARMA INC | Healthcare | 15,734.0 | $547K | 0.16% | +8K | +94.1% | $34.74 | -17.9% |
| 103 | DNTH | DIANTHUS THERAPEUTICS INC | Healthcare | 5,571.0 | $543K | 0.16% | -2K | -25.1% | $97.48 | +10.4% |
| 104 | CTNM | CONTINEUM THERAPEUTICS INC | Healthcare | 33,037.0 | $541K | 0.16% | NEW | — | $16.39 | -6.9% |
| 105 | RGEN | REPLIGEN CORP | Healthcare | 3,902.0 | $532K | 0.16% | NEW | — | $136.44 | +20.9% |
| 106 | NOK | NOKIA CORP | Technology | 39,402.0 | $523K | 0.16% | NEW | — | $13.28 | -25.2% |
| 107 | NKTR | NEKTAR THERAPEUTICS | Healthcare | 7,481.0 | $522K | 0.16% | +2K | +28.5% | $69.81 | -2.2% |
| 108 | SMMT CALL | SUMMIT THERAPEUTICS INC | Healthcare | 2,194.0 | $520K | 0.15% | NEW | — | $236.79 | -92.2% |
| 109 | PHAT | PHATHOM PHARMACEUTICALS INC | Healthcare | 47,663.0 | $517K | 0.15% | +21K | +78.1% | $10.85 | -20.1% |
| 110 | MIRM | MIRUM PHARMACEUTICALS INC | Healthcare | 4,404.0 | $516K | 0.15% | +824.0 | +23.0% | $117.07 | -15.9% |
| 111 | — | ALMONTY INDS INC | — | 30,733.0 | $509K | 0.15% | NEW | — | $16.56 | — |
| 112 | BCYC | BICYCLE THERAPEUTICS PLC | Healthcare | 117,254.0 | $497K | 0.15% | -3K | -2.6% | $4.24 | -9.6% |
| 113 | ALKS | ALKERMES PLC | Healthcare | 9,338.0 | $489K | 0.15% | -16K | -63.5% | $52.40 | -12.5% |
| 114 | FLGT | FULGENT GENETICS INC | Healthcare | 23,793.0 | $488K | 0.15% | NEW | — | $20.52 | -1.9% |
| 115 | — CALL | TENAX THERAPEUTICS INC | — | 782.0 | $481K | 0.14% | NEW | — | $615.51 | — |
| 116 | LQDA | LIQUIDIA CORPORATION | Healthcare | 6,005.0 | $479K | 0.14% | NEW | — | $79.73 | -17.5% |
| 117 | ELVN | ENLIVEN THERAPEUTICS INC | Healthcare | 9,433.0 | $479K | 0.14% | +3K | +42.8% | $50.75 | +7.7% |
| 118 | TRVI | TREVI THERAPEUTICS INC | Healthcare | 25,601.0 | $477K | 0.14% | -2K | -8.3% | $18.65 | -14.9% |
| 119 | MANE | VERADERMICS INC | Healthcare | 3,811.0 | $469K | 0.14% | -5K | -58.5% | $122.94 | -19.6% |
| 120 | VRDN | VIRIDIAN THERAPEUTICS INC | Healthcare | 25,490.0 | $468K | 0.14% | NEW | — | $18.37 | +20.1% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Technology
44.0%
Healthcare
32.3%
Financial Services
7.5%
Consumer Cyclical
5.8%
Energy
3.1%
Basic Materials
2.8%
Industrials
2.6%
Communication Services
1.1%
Consumer Defensive
0.5%
Real Estate
0.2%